Stock market crash! The cheap FTSE 100 shares I’d buy with £5k now

With another 2020 stock market crash right around the corner, there are two cheap FTSE 100 shares I’d buy right now, says Tom Rodgers.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

There’s no need to be scared of a second 2020 stock market crash. In fact, while your portfolio of FTSE 100 shares might suffer in the short term, it actually bodes well for the future.

Buying cheap FTSE 100 shares when the market undervalues them is one of the best ways to profit long term, in my opinion.

No fear of stock market crash

As a committed value investor, I follow Benjamin Graham’s philosophy of “buying from pessimists and selling to optimists“. With the FTSE 100 dipping under 6,000 and fears of another stock market crash rising. there is significant pessimism out there.

But when you’re a long-term investor, you must consider future trends. And there are two I’ll talk about today. Firstly, given everything we’ve seen with Covid-19, healthcare budgets will skyrocket over the next 20 years. And second is the mass switch to online retail.

GlaxoSmithKline

GSK’s defensive characteristics make it one of my favourite FTSE 100 shares, especially with thoughts turning to another stock market crash.

There are few cheap FTSE 100 shares that offer not just solid income, but also value and growth potential at the same time. GlaxoSmithKline (LSE:GSK) is one of them.

GSK has an growing pipeline of branded drugs that gives it a cast-iron economic moat. Just recently, the UK government signed a deal with GSK and French biotech Sanofi to secure up to 60m doses of their experimental coronavirus vaccine.

It is healthcare giants like these that will win the support — and huge cash contracts — from governments going forward.

Unlike FTSE 100 shares that crashed hard in March, GlaxoSmithKline only suffered a loss of around 22% of its value, and rebounded quickly.

Today it trades on a low price-to-earnings ratio of just 12 times, comfortably below the FTSE 100 average of 14.4. And that rock-solid dividend yield is now approaching a hefty 5.3%. Again, this knocks the FTSE 100 average yield of 2.73% into a cocked hat.

The next quarterly payment is due on 8 October 2020, and goes ex-dividend on 13 August. That gives investors a little breathing room to think about their purchase. But I wouldn’t wait.

Kingfisher

Besides a pandemic and the worst stock market crash in a generation, 2020 has been the year everyone realised they could save money and work from home. With most big companies rethinking their vast office spend and allowing more people to work remotely, I see the DIY boom as a multiyear trend.

Millions more will build a home office in the garden, or just refurbish their home as a place to relax and work, too.

And Kingfisher (LSE:KGF), recently promoted to the list of FTSE 100 shares, has made strong gains since the last stock market crash. Today’s share price eclipses its position pre-Covid-19, and how many companies can say that, at a time of historic economic concern?

Even now, the Kingfisher share price is trading at a P/E ratio of 12.8, making it a bargain in my view.

One 2019 report by Retail Economics predicted over half of all retail sales would be online in 10 years time. But the pandemic has vastly accelerated that trend. So the success of retail depends on a solid online offering.

Kingfisher reported in a recent Q2 trading update that sales were up 21.8%, but more importantly that online sales rocketed more than 200% each week in June.

I see this continuing long into the future – far beyond another potential stock market crash.

TomRodgers has no position in any of the shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Growth Shares

2 of the cheapest FTSE 100 stocks to consider buying as we hit 2026

Jon Smith calls out a couple of FTSE 100 companies that have fallen in the past year that he believes…

Read more »

Tesla building with tesla logo and two teslas in front
Investing Articles

Why Tesla stock outperformed the S&P 500 — again — in 2025

As the Tesla share price shrugs off declining revenues and profits to climb 19%, what kind of further excitement will…

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

Thinking of investing in the stock market? Keep these basic rules in mind

Investing in the stock market can put investors on the fast track to building wealth and earning passive income. And…

Read more »

piggy bank, searching with binoculars
US Stock

This Dow Jones stock could be a dark horse outperformer for 2026

Jon Smith looks across the pond and spots a Dow Jones company that has fallen by 11% in the past…

Read more »

Investing Articles

Why Greggs shares crashed 40% in 2025

Greggs has more stores than it had a year ago and total sales are higher, so is a 40% discount…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

4 pros and cons of buying Lloyds shares in 2026!

Investors piled into Lloyds shares last year as the bank delivered strong trading numbers in tough conditions. Could the FTSE…

Read more »

Investing Articles

Prediction: AI stocks will rise again in 2026 and Nvidia’s share price will soar to this level

Can Nvidia and other AI stocks continue to perform in 2026? Edward Sheldon believes so. Here, he explains why he’s…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Investing Articles

3 S&P 500 growth stocks that could make index funds looks silly over the next 5 years

Edward Sheldon believes these three high-flying S&P 500 stocks have the potential to smash the market over the next five…

Read more »